Share

May 09, 2017; 88 (19) ArticleOpen Access

Visual discrimination training improves Humphrey perimetry in chronic cortically induced blindness

Matthew R. Cavanaugh, Krystel R. Huxlin
First published April 12, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003921
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2744

Share

Article Information

vol. 88 no. 19 1856-1864
DOI: 
https://doi.org/10.1212/WNL.0000000000003921
PubMed: 
28404802
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 16, 2016
  • Accepted in final form February 1, 2017
  • First Published April 12, 2017.

Article Versions

Copyright & Usage: 
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Matthew R. Cavanaugh, MS and
    2. Krystel R. Huxlin, PhD
  1. Matthew R. Cavanaugh, MS and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH, EY021209 to KRH, Graduate Student, 2012 to 2015 (2) NIH, T32 EY007125 to CVS, Graduate Student, 2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Krystel R. Huxlin, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Systems and methods for improving visual discrimination”. US Patent No. 7,549,743, Awarded June 23rd, 2009. Inventors: Krystel R. Huxlin, Mary Hayhoe and Jeff Pelz. A system and method for retraining the visual system of a subject with damage to the striate and/or extrastriate visual cortex includes displaying a visual stimulus within a first location of an impaired visual field of the subject; and detecting the subject's perception of an attribute of the visual stimulus. The system and method are believed to effectively recruit undamaged higher level structures in the visual system to assume the functions ofthe damaged structures.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH, EY021209 to Krystel Huxlin (PI), 2011-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. (1) Clerio Vision LLC.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Flaum Eye Institute, University of Rochester, NY.
  1. Correspondence to Dr. Huxlin: huxlin{at}cvs.rochester.edu

Article usage

Article usage: April 2017 to October 2023

AbstractFullPdfSource
Apr 201714663347Highwire
May 2017120381113Highwire
May 201732329pmc
Jun 20172702952Highwire
Jun 2017111716pmc
Jul 201720114549Highwire
Jul 201762936pmc
Aug 20178311242Highwire
Aug 201741419pmc
Sep 20171264396Highwire
Sep 201782017pmc
Oct 20176560100Highwire
Oct 201781936pmc
Nov 20174817123Highwire
Nov 201761918pmc
Dec 2017322323Highwire
Jan 2018514638Highwire
Feb 2018322710Highwire
Mar 2018453139Highwire
Apr 2018202824Highwire
Apr 201832530pmc
May 2018322421Highwire
Jun 2018545014Highwire
Jun 201881411pmc
Jul 2018474020Highwire
Aug 2018403126Highwire
Aug 201811418pmc
Sep 2018503522Highwire
Oct 2018593223Highwire
Nov 2018433729Highwire
Dec 2018432913Highwire
Jan 2019255723Highwire
Feb 201968327Highwire
Mar 201996933Highwire
Apr 201956217Highwire
May 201996130Highwire
Jun 201924818Highwire
Jul 201995225Highwire
Aug 201927915Highwire
Sep 201975125Highwire
Oct 201985012Highwire
Nov 201966418Highwire
Dec 2019126115Highwire
Jan 202087519Highwire
Feb 2020117314Highwire
Mar 202086716Highwire
Apr 202075627Highwire
May 202053319Highwire
Jun 202074320Highwire
Jul 202045617Highwire
Aug 202065632Highwire
Sep 20201511026Highwire
Oct 2020158737Highwire
Nov 2020126236Highwire
Dec 20202112521Highwire
Jan 2021148437Highwire
Feb 2021118830Highwire
Mar 202197619Highwire
Apr 2021159436Highwire
May 2021178238Highwire
Jun 202173917Highwire
Jul 2021175317Highwire
Aug 2021144215Highwire
Sep 2021108818Highwire
Oct 2021128740Highwire
Nov 2021840828Highwire
Dec 20211029713Highwire
Jan 20221410336Highwire
Feb 202298123Highwire
Mar 202246522Highwire
Apr 202287027Highwire
May 2022108127Highwire
Jun 202274918Highwire
Jul 202247018Highwire
Aug 20227518Highwire
Sep 202295523Highwire
Oct 20221217625Highwire
Nov 202236519Highwire
Dec 20220629Highwire
Jan 20233518Highwire
Feb 202383918Highwire
Mar 2023103318Highwire
Apr 202353217Highwire
May 202343528Highwire
Jun 2023123517Highwire
Jul 2023122920Highwire
Aug 202373413Highwire
Sep 202394223Highwire
Oct 202394623Highwire

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles